INTRODUCTION
Mice with specific gene modification are valuable tools for studying development and disease. Traditional gene targeting in embryonic stem (ES) cells, although suitable for generating sophisticated genetic modifications in endogenous genes, is complex and time-consuming (Capecchi, 2005) . The production of genetically modified mice and rats has been greatly accelerated by novel approaches using direct injection of DNA or mRNA of site-specific nucleases into the one-cell-stage embryo, generating DNA double-strand breaks (DSB) at specified sequences leading to targeted mutations (Carbery et al., 2010; Geurts et al., 2009; Shen et al., 2013; Sung et al., 2013; Tesson et al., 2011; Wang et al., 2013) . Coinjection of a single-stranded or double-stranded DNA template containing homology to the sequences flanking the DSB can produce mutant alleles with precise point mutations or DNA inserts (Brown et al., 2013; Cui et al., 2011; Meyer et al., 2010; Wang et al., 2013; Wefers et al., 2013) . Recently, pronuclear injection of two pairs of ZFNs and two double-stranded donor vectors into rat fertilized eggs produced rat containing loxP-flanked (floxed) alleles (Brown et al., 2013) . However, the complex and time-consuming design and generation of ZFNs and double-stranded donor vectors limit the application of this method.
CRISPR (clustered regularly interspaced short palindromic repeat) and Cas (CRISPR-associated) proteins function as the RNA-based adaptive immune system in bacteria and archaea (Horvath and Barrangou, 2010; Wiedenheft et al., 2012) . The type II bacterial CRISPR/Cas system has been demonstrated as an efficient gene-targeting technology that facilitates multiplexed gene targeting (Cong et al., 2013; Wang et al., 2013) . Because the binding of Cas9 is guided by the simple base-pair complementarities between the engineered single-guide RNA (sgRNA) and a target genomic DNA sequence, it is possible to direct Cas9 to any genomic locus by providing the engineered sgRNA (Cho et al., 2013; Cong et al., 2013; Gilbert et al., 2013; Hwang et al., 2013; Jinek et al., 2012; Jinek et al., 2013; Mali et al., 2013b; Qi et al., 2013; Wang et al., 2013) .
Previously, we used the type II bacterial CRISPR/Cas system as an efficient tool to generate mice carrying mutations in multiple genes in one step . However, this study left a number of issues unresolved. For example, neither the efficiency of using the CRISPR/Cas gene-editing approach for the insertion of DNA constructs into endogenous genes nor its utility to create conditional mutant mice was clarified. Here, we report the one-step generation of mice carrying reporter constructs in three different genes as well as the derivation of conditional mutant mice. In addition, we performed an extensive off-target cleavage analysis and show that off-target mutations are rare in targeted mice and ES cells derived from CRISPR/Cas zygote injection.
RESULTS

Targeted Insertion of Short DNA Fragments
In previous work, we introduced precise base pair mutations into the Tet1 and Tet2 genes through homology directed repair (HDR)-mediated genome editing following coinjection of singlestranded mutant DNA oligos, sgRNAs, and Cas9 mRNA . To test whether a larger DNA construct could be inserted at the same DSBs at Tet1 exon 4 and Tet2 exon 3, we designed oligos containing the 34 bp loxP site and a 6 bp EcoRI site flanked by 60 bps sequences on each side adjoining the DSBs (Figure S1A available online). We coinjected Cas9 mRNA, sgRNAs, and single-stranded DNA oligos targeting both Tet1 and Tet2 into zygotes. The restriction fragment length polymorphism (RFLP) assay shown in Figure S1B identified 6 out of 15 tested embryos carrying the loxP site at the Tet1 locus, 8 carrying the loxP site at the Tet2 locus, and 3 had at least one allele of each gene correctly modified. The correct integration of loxP sites was confirmed by sequencing ( Figure S1C ). These results demonstrate that HDR-mediated repair can introduce targeted integration of 40 bp DNA elements efficiently through CRISPR/Cas-mediated genome editing (summarized in Table 1 ).
Mice with Reporters in the Endogenous Nanog, Sox2, and Oct4 Genes Because the study of many genes and their protein products are limited by the availability of high-quality antibodies, we explored the potential of fusing a short epitope tag to an endogenous gene. We designed a sgRNA targeting the stop codon of Sox2 and a corresponding oligo to fuse the 42 bp V5 tag into the last codon ( Figure 1A ). After injection of the sgRNA, Cas9 mRNA, and the oligo into zygotes, in vitro differentiated blastocysts were explanted into culture to derive ES cells. PCR genotyping and sequencing identified 7 out of 16 ES cell lines carrying a correctly targeted insert ( Figures 1B and 1C) . Western blot analysis revealed a protein band at the predicted size using V5 antibody in targeted ES cells but not in the control cells ( Figure 1D ). As expected from a correctly targeted and functional allele, Sox2 expression was seen in targeted blastocysts and ES cells using V5 antibody (Figures 1E and 1F) . Twelve of 35 E13.5 embryos and live-born mice derived from injected zygotes carried the V5 tag correctly targeted into the Sox2 gene as indicated by PCR genotyping and sequencing (data not shown, Table 1 ).
To assess whether a marker transgene could be inserted into an endogenous locus, we coinjected Cas9 mRNA, sgRNA, and a double-stranded donor vector that was designed to fuse a p2A-mCherry reporter with the last codon of the Nanog gene (Figure 2A) . A circular donor vector was used to minimize random integrations. To assess toxicity and to optimize the concentration of donor DNA, we microinjected different amounts of Nanog-2A-mCherry vector. Injection with a high concentration of donor DNA (500 ng/ml) yielded mCherry-positive embryos with high efficiency, with most blastocysts being retarded, whereas injection with a lower donor DNA concentration (10 ng/ml) yielded mostly healthy blastocysts, most of which were mCherry-negative. When 200 ng/ml donor DNA was used, 75% (936/1,262) of the injected zygotes developed to blastocysts, 9% (86/936) of which were mCherry-positive ( Figure 2C ; Table S1 ). mCherry was mainly expressed in the inner cell mass (ICM), consistent with targeted integration of the mCherry transgene into the Nanog gene. We derived six ES cell lines from mCherry-positive blastocysts, four of which uniformly expressed mCherry with the signal disappearing upon cellular differentiation ( Figure 2C ). The other two lines showed variegated mCherry expression, with some colonies being mCherry positive and others negative ( Figure S2A , Table S2 ) consistent with mosaic donor embryos, which would be expected if transgene insertion occurred later than the zygote stage, as has been previously observed with ZNF and TALEN-mediated targeting (Brown et al., 2013; Cui et al., 2011; Wefers et al., 2013) . Correct transgene integration in ES cell lines was confirmed by Southern blot analysis ( Figure 2B ). We also generated mice from injected zygotes. Southern blot analysis (Figures S2B and S2C) revealed that 7 out of 86 E13.5 embryos and live-born mice carried the mCherry transgene in the Nanog locus. One targeted mouse was mosaic (Table S2) , because the intensity of targeted allele was lower than the wild-type allele ( Figure S2B, #6) . Two of the mice carried an additional randomly integrated transgene (Figure S2C, #3 ). As summarized in Tables 1 and S1, the efficiency of targeted insertion of the transgene was about 10% in blastocysts and mice derived from injected zygotes.
Finally, we designed sgRNA targeting the Oct4 3 0 UTR, which was coinjected with a published donor vector designed to integrate the 3 kb transgene cassette (IRES-eGFP-loxP-Neo-loxP; Figure 2D ) at the 3 0 end of the Oct4 gene (Lengner et al., 2007) . Blastocysts were derived from injected zygotes, inspected for GFP expression, and explanted to derive ES cells. About 20% (47/254) of the blastocysts displayed uniform GFP expression in the ICM region. Three of nine derived ES cell lines expressed GFP ( Figure 2E ), including one showed mosaic expression (Table  S2 ). Three out of ten live-born mice contained the targeted allele (Table 1) . Correct targeting in mice and ES cell lines was confirmed by Southern blot analysis ( Figure 2F ). The sgRNA coding sequence is underlined, capitalized, and labeled in red. The protospacer-adjacent motif (PAM) sequence is labeled in green. The stop codon of Sox2 is labeled in orange. The oligo contained 60 bp homologies on both sides flanking the DSB. In the oligo donor sequence, the V5 tag sequence is labeled as a green box. PCR primers (SF, V5F, and SR) used for PCR genotyping are shown as red arrowheads.
(B) Top: PCR genotyping using primers V5F and SR produced bands with correct size in targeted ES samples T1 to T5, but not in WT sample. Bottom: PCR genotyping using primers SF and SR produced slightly larger products, indicating the 42 bp V5 tag sequence was integrated. T1 only contain larger product, suggesting either both alleles were targeted, or one allele failed to amplify. (C) PCR products using primers SF and SR were cloned into plasmid and sequenced. Sequence across the targeting region confirmed correct fusion of V5 tag to the last codon of Sox2.
(D) Western blot analysis identified Sox2-V5 protein using V5 antibody in ES cells containing Sox2-V5 allele. Beta-actin was shown as the loading control. Because beta-actin and Sox2-V5 run at the same size, the samples for the V5 signal and beta-actin were run in parallel on the same gel.
(E) Immunostaining of targeted blastocyst using V5 antibody showed signal in ICM. Scale bar, 50 mm.
(F) Immunostaining of targeted ES cells using V5 antibody showed uniform Sox2 expression. Scale bar, 100 mm.
Conventionally, transgenic mice are generated by pronuclear instead of cytoplasmic injection of DNA. To optimize the generation of CRISPR/Cas9-targeted embryos, we compared different concentrations of RNA and the Nanog-mCherry or the Oct4-GFP DNA vectors as well as three different delivery modes: (1) simultaneous injection of all constructs into the cytoplasm, (2) simultaneous injection of the RNA and the DNA into the pronucleus, and (3) injection of Cas9/sgRNA into the cytoplasm followed 2 hr later by pronuclear injection of the DNA vector. Table  S1 shows that simultaneous injection of all constructs into the cytoplasm at a concentration of 100 ng/ml Cas9 RNA, 50 ng/ml of sgRNA and 200 ng/ml of vector DNA was optimal, resulting in 9% (86/936) to 19% (47/254) of targeted blastocysts. Similarly, the simultaneous injection of 5 ng/ml Cas9 RNA, 2.5 ng/ml of sgRNA, and 10 ng/ml of DNA vector into the pronucleus yielded between 9% (7/75) and 18% (13/72) targeted blastocysts. In contrast, the two-step procedure with Cas9 and sgRNA simultaneous injected into the cytoplasm followed 2 hr later by pronuclear injection of different concentrations of DNA vector yielded no or at most 3% (1/34) positive blastocysts. Thus, our results suggest that simultaneous injection of RNA and DNA into the cytoplasm or nucleus is the most efficient procedure to achieve targeted insertion.
Conditional Mecp2 Mutant Mice
We investigated whether conditional mutant mice can be generated in one step by insertion of two loxP sites into the same allele of the Mecp2 gene. To derive conditional mutant mice similar to those previously described using traditional homologous recombination methods in ES cells (Chen et al., 2001) , we designed two sgRNAs targeting Mecp2 intron 2 (L1, L2) and two sgRNAs targeting intron 3 (R1, R2), as well as the corresponding loxP site oligos with 60 bp homology to sequences on each side surrounding each sgRNA-mediated DSB ( Figure S3A ). To facilitate detection of correct insertions, the oligos targeting intron 2 were engineered to contain a NheI restriction site and the oligos targeting intron 3 to contain an EcoRI site in addition to the loxP sequences ( Figures 3A and S3A) . To determine the efficiency of single loxP site integration at the Mecp2 locus, we injected Cas9 mRNA and each single sgRNA and corresponding oligo into zygotes, which were cultured to the blastocyst stage and genotyped by the RFLP assay. As shown in Figure S3B , the L2 and R1 sgRNAs were more efficient in integrating the oligos with four out of eight embryos carrying the L2 oligo and two out of six embryos carrying the R1 oligo. Therefore, L2 and R1 sgRNAs and the corresponding oligos were chosen for the generation of a floxed allele ( Figure 3A) .
A total of 98 E13.5 embryos and mice were generated from zygotes injected with Cas9 mRNA, sgRNAs, and DNA oligos targeting the L2 and R1 sites. Genomic DNA was digested with both NheI and EcoRI, and analyzed by Southern blot using exon 3 and exon 4 probes ( Figures 3A and 3B) . The L2 and R1 oligos contained, in addition to the loxP site, different restriction sites (NheI or EcoRI). Thus, single loxP site integration at L2 or R1 will produce either a 3.9 kb or a 2 kb band, respectively, when hybridized with the exon3 probe ( Figures 3A and B) . We found that about 50% (45/98) of the embryos and mice carried a loxP site at the L2 site and about 25% (25/98) at the R1 site. Importantly, integration of both loxP sites on the same DNA molecule, generating a floxed allele, produces a 700 bp band as detected by exon 3 probe hybridization ( Figures 3A and 3B ). RFLP analysis, sequencing ( Figures S4A and S4B ) and Southern blot analysis ( Figure 3B) showed that 16 out of the 98 mice tested contained two loxP sites flanking exon 3 on the same allele. Table 2 summarizes the frequency of all alleles and shows that the overall insertion frequency of an L2 or R1 insertion was slightly higher in females (21/38) than in males (28/60) consistent with the higher copy number of the X-linked Mecp2 gene in females. To confirm that the floxed allele was functional, we used genomic DNA for in vitro Cre-mediated recombination. Upon Cre treatment, both the deletion and circular products were detected by PCR in targeted mice, but not in DNA from wild-type mice ( Figure 3C ). The PCR products were sequenced and confirmed the precise Cre-loxP-mediated recombination ( Figure S4C ).
We noticed that some pups carried large deletions but no loxP insertions, raising the possibility that two cleavage events may generate defined deletions. To confirm this notion, we coinjected Cas9 mRNA, Mecp2-L2, and R1 sgRNAs but without oligos. PCR genotyping and sequencing ( Figures 3D and 3E ) revealed that 8 out of 23 mice carried deletions of about 700 bp spanning the L2 and R1 sites removing exon 3. This was confirmed by Southern analysis (data not shown). Because DNA breaks are repaired through the nonhomologous end joining (NHEJ) pathway, the ends of the breaks are different in different deletion alleles ( Figure 3E ).
Mosaicism
As mentioned above, we noted that some animals were mosaic for the targeted insertion. We decided to characterize the frequency of mosaicism in Mecp2-targeted mice by Southern blot analysis. Because Mecp2 is an X-linked gene, in males more than one allele and in females more than two different alleles suggest mosaicism, which would be expected if integration occurred after the zygote stage. For example, as shown in Figure 3B , female mouse #2 contained three different alleles (one WT allele, one floxed allele, and one L2-loxP allele), and female mouse #4 contained four different alleles (one WT allele, one floxed allele, one L2-loxP allele, and one R1-loxP allele). Male mouse #5 contained two different alleles, with each allele carrying a single loxP site ( Figure 3B ). We identified eight mosaics out of 16 mice containing a Mecp2 floxed allele. The frequency of mosaicism among 49 embryos and mice containing loxP site was about 40% (20/49) (Table S2) . Because Southern blot analysis cannot detect small in-del mutations caused by NHEJ repair, it is possible that this underestimates the overall mosaicism frequency.
Off-Target Analysis
Two recent studies identified a high level of off-target cleavage in human cell lines using the CRISPR/Cas system, with Cas9-targeting specificity being shown to tolerate small numbers of mismatches between sgRNA and target DNA in a sequence and position-dependent manner Hsu et al., 2013) . Similarly, using a transcription-based method, Mali et al. (2013a) reported that Cas9/sgRNA binding could tolerate up to three mismatches.
We characterized potential off-target (OT) mutations in mice and ES cell lines derived from zygotes injected with Cas9 and sgRNAs targeting the Sox2, the Nanog, the Oct4, and the Mecp2 gene. We identified all genomic loci containing up to three or four base pair mismatches compared to the 20 bp sgRNA coding sequence (Table S3) . We amplified all 13 potential OT sites of Sox2 sgRNA in six mice and four ES cell lines carrying the Sox2-V5 allele and tested for potential off target mutations using the Surveyor assay. No mutation was detected in any locus. When nine Nanog sgRNA potential OT sites (including seven genomic loci containing four base pair mismatches in the PAM distal region) were tested in five correctly targeted mice and four targeted ES cell lines, mutations were found in seven samples at OT1 (Table S3 ). Since Nanog OT1 has only one base pair difference at the very 5 0 end of the sgRNA (position 20, numbered 1-20 in the 3 0 to 5 0 direction of sgRNA target site), it may not be surprising to find such a high frequency of mutations at this locus. In contrast, no off-target mutation was seen in any other Nanog OTs, which contain three or four base pair difference. For Oct4, we tested all 11 OT sites containing up to three base pair mismatches in three targeted mice and three targeted ES cell lines. Mutations were found in four out of six samples at OT1, which has only one base pair mismatch at position 19, whereas no off-target mutation was identified in any other Oct4 OTs, which contain two or three base pair mismatches (Table S3) . Finally, four potential off-targets sites for Mecp2 L2, and ten sites for Mecp2 R1 were analyzed in ten mice carrying a Mecp2 floxed allele. Only one off-target mutation was identified in one mouse at the Mecp2 R1 OT2 (Table S3) . In summary, we tested all potential off-target sites differing by up to three or four base pairs in 35 mice or ES cell lines and only identified mutations in one off-target site for Nanog (OT1 7/9 samples, one mismatch at position 20), Oct4 (OT1 4/6 samples, 1 mismatch at position 19), and Mecp2 (R1-OT2 1/10 samples, two mismatches at positions 7 and 20). No off target mutation was identified in any genomic locus containing three base pair mismatches. Thus, although the off-target mutation rate was lower than what had been observed in the previous studies using cultured human cancer cell lines, our results are consistent with the conclusion that two or more interspaced mismatches dramatically reduce Cas9 cleavage Hsu et al., 2013) .
DISCUSSION
In this study, we demonstrate that CRISPR/Cas technology can be used for efficient one-step insertions of a short epitope or longer fluorescent tags into precise genomic locations, which will facilitate the generation of mice carrying reporters in endogenous genes. Mice and embryos carrying reporter constructs in the Sox2, the Nanog and the Oct4 gene were derived from zygotes injected with Cas9 mRNA, sgRNAs, and DNA oligos or vectors encoding a tag or a fluorescent marker. Moreover, microinjection of two Mecp2-specific sgRNAs, Cas9 mRNA, and two different oligos encoding loxP sites into fertilized eggs allowed for the one-step generation of conditional mutant mice. In addition, we show that the introduction of two spaced sgRNAs targeting the Mecp2 gene can produce mice carrying defined deletions of about 700 bp. Though all RNA and DNA constructs were injected into the cytoplasm or nucleus of zygotes, the gene modification events could happen at the one-cell stage or later. Indeed, Southern analyses revealed mosaicism in 17% (1/6) to 40% (20/49) of the targeted mice and ES cell lines indicating that the insertion of the transgenes had occurred after the zygote stage (Table S2) .
Our previous experiments ) demonstrated an efficiency of CRISPR/Cas sgRNA-mediated cleavage that was high enough to allow for the one-step production of engineered mice up to 90% of which carried homozygous mutations in two genes (four mutant alleles). The results reported here show that the sgRNA-mediated DSBs occur at a significantly higher frequency than insertion of exogenous DNA sequences. Therefore, the allele not carrying the insert will likely be mutated as a consequence of NHEJ-based gene disruption. Thus, the reporter allele would need to be segregated away from the mutant allele in order to produce mice carrying a reporter as well as a wild-type allele.
Two recent studies reported a high off-target mutation rate in CRISPR/Cas9-transfected human cell lines Hsu et al., 2013) . We analyzed the off-target rate for five different sgRNAs and identified cleavage of Nanog OT1, Oct4 OT1, and Mecp2 R1 OT2. Nanog OT1 has only one base pair difference from the targeting sequence at the extreme 5 0 end (position 20), whereas Oct4 OT1 contains one base pair mismatch at position 19; and Mecp2 R1 OT2 has one base pair mismatch The PAM sequence is labeled in green. In the oligo donor sequence, the loxP site is indicated as an orange box, and the restriction site sequences are in bold and capitalized. The oligo contained 60 bp homologies on both sides flanking the DSB. Restriction enzymes used for RFLP and Southern blot analysis are shown, and the Southern blot probes are shown as red boxes.
(B) Southern analysis of targeted alleles. Data of five mice are shown. EcoRI/NheI-digested genomic DNA was hybridized with the exon3 probe. Expected fragment size: WT = 5.2 kb, 2loxP = 0.7 kb, L2-loxP = 3.9 kb, and R1-loxP = 2 kb. The blot was then stripped and hybridized with the exon 4 probe. Expected fragment size: WT = 5.2 kb, 2loxP = 3.2 kb, L2-loxP = 3.9 kb, and R1-loxP = 3.2 kb. The sequence of the floxed allele is shown in Figure S4B .
(legend continued on next page) at position 20, and one mismatch at position 7. Thus, the only offtarget mutations in 2 bp mismatch targets were seen when one of the mismatches was at the distal 5 0 end. This result is consistent with previous findings that Cas9 can catalyze DNA cleavage in the presence of single-base mismatches in the PAM distal region (Cong et al., 2013; Hsu et al., 2013; Jiang et al., 2013; Jinek et al., 2012) . No mutations were detected in 42 potential OTs of Sox2, Nanog, Oct4, or Mecp2 containing 3 or 4 bp mismatches in a total of 35 mice and ES cell lines tested, consistent with the observation that three or more interspaced mismatches dramatically reduce Cas9 cleavage . Thus, for designing the most suitable target sequences for generating Cas9 cleavage-mediated, genetically modified mice, it is important to avoid targeting sites that have only one or two mismatches in other genomic loci. This is particularly important for mismatches that are at the PAM distal region.
We consider several possibilities to explain the lower offtarget cleavage rate seen in animals derived from manipulated zygotes and the results reported for CRISPR/Cas-treated human cell lines Hsu et al., 2013) . (1) In our study, the off-target mutagenesis was based on the analysis of a ''clonal genome'' in animals derived from a single manipulated zygote in contrast to the previous reports that analyzed heterogeneous cell populations. The surveyor assay, based upon extensive PCR amplification, may identify any mutation, even very rare alleles that may be present in the heterogeneous population. (2) The transformed human cell lines may have different DNA damage responses resulting in a different mutagenesis rate than the normal one-cell embryo. (3) In our experiments CRISPR/ Cas was injecting as short-lived RNA in contrast to Fu et al. (2013) and Hsu et al. (2013) , who used DNA plasmid transfection, which may express the Cas9/sgRNA for longer time periods leading to more extensive cleavage. Thus, our data suggest high specificity of the CRISPR/Cas9 system for gene editing in early embryos aimed at generating gene-modified mice. Nevertheless, future characterization of off-target mutagenesis of CRISPR/Cas system using whole-genome sequencing would be highly informative and may allow designing sgRNAs with higher specificity.
In summary, CRISPR/Cas-mediated genome editing represents an efficient and simple method of generating sophisticated genetic modifications in mice such as conditional alleles and endogenous reporters in one step. The principles described in this study could be directly adapted to other mammalian species, opening the possibility of sophisticated genome engineering in many species where ES cells are not available.
EXPERIMENTAL PROCEDURES
Production of Cas9 mRNA and sgRNA Bicistronic expression vector px330 expressing Cas9 and sgRNA (Cong et al., 2013) was digested with BbsI and treated with Antarctic Phosphatase, and the linearized vector was gel purified. A pair of oligos (Table S4) for each targeting site was annealed, phosphorylated, and ligated to the linearized vector.
T7 promoter was added to Cas9 coding region by PCR amplification using primer Cas9 F and R (Table S4 ). T7-Cas9 PCR product was gel purified and used as the template for in vitro transcription (IVT) using mMESSAGE mMACHINE T7 ULTRA kit (Life Technologies). T7 promoter was added to sgRNAs template by PCR amplification using primer listed in Table S4 . The T7-sgRNA PCR product was gel purified and used as the template for IVT using MEGAshortscript T7 kit (Life Technologies). Both the Cas9 mRNA and the sgRNAs were purified using MEGAclear kit (Life Technologies) and eluted in RNase-free water.
Single-Stranded and Double-Stranded DNA Donors All single-stranded oligos were ordered as Ultramer DNA oligos from Integrated DNA Technologies. Nanog-2A-mCherry vector was modified from previously published targeting vector Nanog-2A-mCherry-PGK-Neo (Faddah et al., 2013) . Nanog-2A-mCherry-PGK-Neo was digested with PacI and AscI to drop out the PGK-Neo cassette; the 9.7 kb fragment was gel purified and blunt-ended using T4 DNA polymerase (New England Biolabs) then selfligated using T4 DNA ligase (New England Biolabs). Oct4-IRES-eGFP-PGKNeo vector is previously published (Lengner et al., 2007) . These male mice were mosaic.
(C) In vitro Cre-mediated recombination of the floxed Mecp2 allele. The genomic DNA of targeted mice #1 and #3 was incubated with Cre recombinase, and used as PCR template. Primers DF and DR flanking the floxed allele produce shorter products upon Cre-dependent excision. Primers CF and CR detect the circular molecule, which only form upon Cre-loxP recombination. The position of each primer is shown at the bottom cartoon. The deletion and circular PCR products were sequenced and the sequences are shown in Figure S4C . (D) Injection of Cas9 mRNA and both L2 and R1 sgRNA generated Mecp2 mutant allele with deletion of exon 3. PCR genotyping using primers DF and DR identified defined deletion events in mice #1, #6, and #8 (indicated by stars).
(E) Sequences of three mutant alleles with exon 3 deletions in three mice. R2 and L1 sgRNA coding sequences were underlined, capitalized, and labeled in red. The PAM sequence is labeled in green. See also Figures S3 and S4 .
Suveryor Assay and RFLP Analysis for Genome Modification
Suveryor assay was performed as described (Guschin et al., 2010) . Genomic DNA from targeted and control mice or embryos was extracted and PCR was performed using gene-specific primers (Table S4 ) under the following conditions: 95 C for 5 min; 35 3 (95 C for 30 s, 60 C for 30 s, 68 C for 40 s); 68 C for 2 min; hold at 4 C. PCR products were then denatured, annealed, and treated with Suveryor nuclease (Transgenomic). DNA concentration of each band was measured on an ethidium-bromide-stained 10% acrylamide Criterion TBE gel (BioRad) and quantified using ImageJ software. For RFLP analysis, 10 ml of Tet1, Tet2, Mecp2-R1, R2 PCR product was digested with EcoRI, 10 ml of Mecp2-L1, and L2 PCR product was digested with NheI. Digested DNA was separated on an ethidium-bromide-stained agarose gel (2%). For sequencing, PCR products were cloned using the Original TA Cloning Kit (Invitrogen), and mutations were identified by Sanger sequencing.
One-Cell Embryo Injection
All animal procedures were performed according to NIH guidelines and approved by the Committee on Animal Care at MIT. B6D2F1 (C57BL/6 X DBA2) female mice and ICR mouse strains were used as embryo donors and foster mothers, respectively. Superovulated female B6D2F1 mice (7-8 weeks old) were mated to B6D2F1 stud males, and fertilized embryos were collected from oviducts. Different concentrations of Cas mRNA, sgRNA, and oligos or plasmid vectors were mixed and injected into the cytoplasm or pronucleus of fertilized eggs with well-recognized pronuclei in M2 medium (Sigma). The injected zygotes were cultured in KSOM with amino acids at 37 C under 5% CO2 in air until blastocyst stage by 3.5 days. Thereafter, 15-25 blastocysts were transferred into uterus of pseudopregnant ICR females at 2.5 dpc.
Southern Blotting
Genomic DNA was separated on a 0.8% agarose gel after restriction digests with the appropriate enzymes, transferred to a nylon membrane (Amersham) and hybridized with 32 P random primer (Stratagene)-labeled probes. Between hybridizations, blots were stripped and checked for complete removal of radioactivity before rehybridization with a different probe.
In Vitro Cre Recombination A 20 ml reaction containing 1 mg of genomic DNA and 10 units of recombinant Cre recombinase (New England Biolabs) in 13 buffer was incubated at 37 C for 1 hr. For all targets, 1 ml of the Cre reaction mix was used as template for PCR reactions with gene-specific primers. For each target, primers DF and DR were used for detecting the deletion products, and primers CF and CR were used to detect the circle product. All products were sequenced.
Immunostaining and Western Blot Analysis
For immunostaining, cells in 24-well were fixed in PBS supplemented with 4% paraformaldehyde for 15 min at room temperature (RT). The cells were then permeabilized using 0.2% Triton X-100 in PBS for 15 min at RT. The cells were blocked for 30 min in 1% BSA in PBS. Primary antibody against V5 (ab9137, abcam) was diluted in the same blocking buffer and incubated with the samples overnight at 4 C. The cells were treated with a fluorescently coupled secondary antibody and then incubated for 1 hr at RT. The nuclei were stained with Hoechst 33342 (Sigma) for 5 min at RT. For western blot, Cell pellets were lysed on ice in Laemmli buffer (62.5 mM Tris-HCl [pH 6.8], 2% sodium dodecyl sulfate, 5% beta-mercaptoethanol, 10% glycerol, and 0.01% bromophenol blue) for 30 min in presence of protease inhibitors (Roche Diagnostics), boiled for 5-7 min at 100 C, and subjected to western blot analysis. Primary antibodies: V5 (1:1,000, ab9137, Abcam), beta-actin (1:2,000). Blots were probed with anti-goat, or anti-rabbit IgG-HRP secondary antibody (1:10,000) and visualized using ECL detection kit (GE Healthcare).
ESC Derivation and Differentiation
Morulas or blastocysts were selected to generate ES cell lines. The zona pellucida was removed using acid Tyrode solution. Each embryo was transferred into one well of a 96-well plate seeded with ICR embryonic fibroblast feeders in ESC medium supplemented with 20% knockout serum replacement, 1,500 U/ml leukemia inhibitory factor (LIF), and 50 mM of the MEK1 inhibitor (PD098059). After 4-5 days in culture, the colonies were trypsinized and transferred to a 96-well plate with a fresh feeder layer in fresh medium. Clonal expansion of the ESCs proceeded from 48-well plates to 6-well plates with feeder cells and then to 6-well plates for routine culture. For ESC differentiation, cells were harvested by trypsinization and transferred to bacterial culture dishes in the ES medium without or LIF. After 3 days, aggregated cells were plated onto gelatin-coated tissue culture dishes and incubated for another 3 days.
Prediction of Potential Off-Targets
Potential off-targets were predicted by searching the mouse genome (mm9) for matches to the 20 nt sgRNA sequence allowing for up to four mismatches (Nanog) or three mismatches (Sox2, Oct4, Mecp2-L2, and Mecp2-R1) followed by NGG PAM sequence. Matches were ranked first by ascending number of mismatches then by ascending distance from the PAM sequence.
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